Daito Pharmaceutical Co.,Ltd. (4577.T)
JPY 2088.0
(-0.29%)
JPY 2088.0
(-0.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 77.7 Billion JPY | 10.14% |
| 2022 | 70.55 Billion JPY | 8.64% |
| 2021 | 64.93 Billion JPY | 12.47% |
| 2020 | 57.73 Billion JPY | 6.43% |
| 2019 | 54.24 Billion JPY | 16.04% |
| 2018 | 46.74 Billion JPY | -0.95% |
| 2017 | 47.19 Billion JPY | 3.26% |
| 2016 | 45.7 Billion JPY | 5.46% |
| 2015 | 43.34 Billion JPY | 2.45% |
| 2014 | 42.3 Billion JPY | 15.29% |
| 2013 | 36.69 Billion JPY | 5.56% |
| 2012 | 34.76 Billion JPY | 16.22% |
| 2011 | 29.9 Billion JPY | 2.88% |
| 2010 | 29.07 Billion JPY | 4.89% |
| 2009 | 27.71 Billion JPY | 5.17% |
| 2008 | 26.35 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 81.92 Billion JPY | 5.43% |
| 2023 Q2 | 74.99 Billion JPY | 4.86% |
| 2023 FY | 77.7 Billion JPY | 10.14% |
| 2023 Q3 | 77.35 Billion JPY | 3.15% |
| 2023 Q4 | 77.7 Billion JPY | 0.46% |
| 2023 Q1 | 71.51 Billion JPY | 1.37% |
| 2022 Q1 | 69.42 Billion JPY | 6.9% |
| 2022 FY | 70.55 Billion JPY | 8.64% |
| 2022 Q4 | 70.55 Billion JPY | 2.84% |
| 2022 Q3 | 68.6 Billion JPY | -3.55% |
| 2022 Q2 | 71.12 Billion JPY | 2.45% |
| 2021 FY | 64.93 Billion JPY | 12.47% |
| 2021 Q1 | 58.72 Billion JPY | 1.72% |
| 2021 Q2 | 60.96 Billion JPY | 3.8% |
| 2021 Q3 | 62.67 Billion JPY | 2.82% |
| 2021 Q4 | 64.93 Billion JPY | 3.6% |
| 2020 Q2 | 57.07 Billion JPY | 4.61% |
| 2020 Q3 | 59.3 Billion JPY | 3.9% |
| 2020 Q4 | 57.73 Billion JPY | -2.64% |
| 2020 Q1 | 54.56 Billion JPY | 0.58% |
| 2020 FY | 57.73 Billion JPY | 6.43% |
| 2019 Q3 | 52.27 Billion JPY | 4.84% |
| 2019 FY | 54.24 Billion JPY | 16.04% |
| 2019 Q4 | 54.24 Billion JPY | 3.78% |
| 2019 Q1 | 48.41 Billion JPY | 3.56% |
| 2019 Q2 | 49.85 Billion JPY | 2.98% |
| 2018 FY | 46.74 Billion JPY | -0.95% |
| 2018 Q3 | 49.19 Billion JPY | 1.29% |
| 2018 Q2 | 48.56 Billion JPY | 2.37% |
| 2018 Q1 | 47.43 Billion JPY | 0.52% |
| 2018 Q4 | 46.74 Billion JPY | -4.97% |
| 2017 Q2 | 47.69 Billion JPY | 2.44% |
| 2017 FY | 47.19 Billion JPY | 3.26% |
| 2017 Q4 | 47.19 Billion JPY | 0.02% |
| 2017 Q3 | 47.18 Billion JPY | -1.06% |
| 2017 Q1 | 46.55 Billion JPY | 1.85% |
| 2016 Q4 | 45.7 Billion JPY | 0.29% |
| 2016 FY | 45.7 Billion JPY | 5.46% |
| 2016 Q1 | 42.91 Billion JPY | -0.98% |
| 2016 Q3 | 45.57 Billion JPY | 1.62% |
| 2016 Q2 | 44.84 Billion JPY | 4.5% |
| 2015 Q4 | 43.34 Billion JPY | -2.79% |
| 2015 Q3 | 44.58 Billion JPY | 6.08% |
| 2015 Q2 | 42.02 Billion JPY | -0.59% |
| 2015 FY | 43.34 Billion JPY | 2.45% |
| 2015 Q1 | 42.27 Billion JPY | -0.07% |
| 2014 Q1 | 40.02 Billion JPY | 9.09% |
| 2014 Q3 | 40.55 Billion JPY | 0.14% |
| 2014 Q4 | 42.3 Billion JPY | 4.33% |
| 2014 FY | 42.3 Billion JPY | 15.29% |
| 2014 Q2 | 40.49 Billion JPY | 1.16% |
| 2013 Q1 | 35.44 Billion JPY | 1.96% |
| 2013 Q3 | 34.79 Billion JPY | -3.71% |
| 2013 Q4 | 36.69 Billion JPY | 5.46% |
| 2013 FY | 36.69 Billion JPY | 5.56% |
| 2013 Q2 | 36.13 Billion JPY | 1.95% |
| 2012 Q1 | 32.2 Billion JPY | 7.67% |
| 2012 FY | 34.76 Billion JPY | 16.22% |
| 2012 Q3 | 34.76 Billion JPY | 5.37% |
| 2012 Q2 | 32.99 Billion JPY | 2.45% |
| 2012 Q4 | 34.76 Billion JPY | -0.0% |
| 2011 Q1 | 29.96 Billion JPY | 3.09% |
| 2011 Q2 | 30.39 Billion JPY | 1.41% |
| 2011 FY | 29.9 Billion JPY | 2.88% |
| 2011 Q3 | 30.83 Billion JPY | 1.47% |
| 2011 Q4 | 29.9 Billion JPY | -3.01% |
| 2010 Q2 | 28.57 Billion JPY | 2.18% |
| 2010 Q4 | 29.07 Billion JPY | -1.6% |
| 2010 Q3 | 29.54 Billion JPY | 3.38% |
| 2010 FY | 29.07 Billion JPY | 4.89% |
| 2010 Q1 | 27.96 Billion JPY | 0.0% |
| 2009 FY | 27.71 Billion JPY | 5.17% |
| 2008 FY | 26.35 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -112.474% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.486% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 91.437% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 94.516% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -403.908% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 70.499% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 54.722% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 94.425% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -352.238% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 76.365% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 51.065% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -1.632% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -56.834% |
| Tsumura & Co. | 428.25 Billion JPY | 81.855% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 70.219% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 41.762% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 81.956% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 8.935% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 48.378% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 56.265% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -416.469% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -406.174% |
| MedRx Co., Ltd | 2.05 Billion JPY | -3686.94% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -310.105% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -2947.373% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -3735.68% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 16.722% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 79.659% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -1743.69% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 89.953% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -142.807% |